Cooper/Haims Advisors, LLC Novartis Ag Transaction History

Cooper/Haims Advisors, LLC

  • $179 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Jul 26, 2019
SELL
$75.4 - $92.8 $170,856 - $210,284
-2,266 Closed
0 $0
Q1 2019

Apr 29, 2019
SELL
$75.32 - $86.15 $146,648 - $167,734
-1,947 Reduced 46.21%
2,266 $218,000
Q1 2019

Apr 26, 2019
BUY
$75.32 - $86.15 $317,323 - $362,949
4,213 New
4,213 $405,000

Others Institutions Holding NVS

# of Institutions
1,435
Shares Held
133M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cooper/Haims Advisors, LLC Portfolio

Follow Cooper/Haims Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cooper/Haims Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cooper/Haims Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email